ClinicalTrials.gov
ClinicalTrials.gov Menu

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00170573
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : March 25, 2016
Sponsor:
Information provided by (Responsible Party):
North Eastern Germany Society of Gynaecologic Oncology

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2009
  Actual Study Completion Date : August 2010

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 4, 2016
November 23, 2016
2 December 12, 2016
February 3, 2017